Variant report

Variant	nsv581501
Chromosome Location	chr2:40256218-40285145
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CCNT2	chr2:40279953-40280153	K562	blood:	n/a	n/a
2	CEBPB	chr2:40258064-40258380	A549	lung:	n/a	chr2:40258206-40258217
3	CEBPB	chr2:40258083-40258389	HepG2	liver:	n/a	chr2:40258206-40258217
4	CEBPB	chr2:40259963-40260548	IMR90	lung:	n/a	n/a
5	CEBPB	chr2:40269113-40269506	IMR90	lung:	n/a	n/a
6	CEBPB	chr2:40258067-40258360	K562	blood:	n/a	chr2:40258206-40258217
7	CEBPB	chr2:40258041-40258398	IMR90	lung:	n/a	chr2:40258206-40258217
8	CEBPB	chr2:40266300-40266894	IMR90	lung:	n/a	n/a
9	CTCF	chr2:40265760-40266050	GM12868	blood:	n/a	n/a
10	CTCF	chr2:40261440-40261590	HMF	breast:	n/a	n/a
11	CTCF	chr2:40269320-40269470	HPAF	blood vessel:	n/a	n/a
12	CTCF	chr2:40283919-40283999	GM10248	blood:	n/a	n/a
13	CTCF	chr2:40269320-40269470	AG10803	skin:	n/a	n/a
14	CTCF	chr2:40269280-40269430	AG10803	skin:	n/a	n/a
15	CTCF	chr2:40269220-40269370	HBMEC	blood vessel:	n/a	n/a
16	CTCF	chr2:40269320-40269470	HMF	breast:	n/a	n/a
17	CTCF	chr2:40273874-40273939	GM13976	blood:	n/a	n/a
18	EP300	chr2:40276711-40277358	SK-N-SH_RA	brain:	n/a	n/a
19	EP300	chr2:40275537-40278528	SK-N-SH	brain:	n/a	chr2:40276359-40276373
20	EP300	chr2:40256366-40256371	GM12878	blood:	n/a	n/a
21	EP300	chr2:40260044-40260383	SK-N-SH_RA	brain:	n/a	n/a
22	EP300	chr2:40259881-40260636	SK-N-SH	brain:	n/a	n/a
23	EP300	chr2:40259841-40260665	SK-N-SH	brain:	n/a	n/a
24	EP300	chr2:40276687-40277393	SK-N-SH_RA	brain:	n/a	n/a
25	FOS	chr2:40269241-40269462	MCF10A-Er-Src	breast:	n/a	chr2:40269317-40269325 chr2:40269317-40269325 chr2:40269316-40269326 chr2:40269316-40269326 chr2:40269316-40269326 chr2:40269316-40269326 chr2:40269317-40269324
26	FOS	chr2:40261362-40261599	MCF10A-Er-Src	breast:	n/a	chr2:40261493-40261504
27	FOS	chr2:40261294-40261697	HUVEC	blood vessel:	n/a	chr2:40261493-40261504
28	FOS	chr2:40266703-40267038	HUVEC	blood vessel:	n/a	chr2:40266882-40266891 chr2:40266882-40266889 chr2:40266880-40266891 chr2:40266881-40266891 chr2:40266881-40266891 chr2:40266804-40266816
29	FOS	chr2:40269199-40269376	MCF10A-Er-Src	breast:	n/a	chr2:40269317-40269325 chr2:40269317-40269325 chr2:40269316-40269326 chr2:40269316-40269326 chr2:40269316-40269326 chr2:40269316-40269326 chr2:40269317-40269324
30	FOS	chr2:40269225-40269393	MCF10A-Er-Src	breast:	n/a	chr2:40269317-40269325 chr2:40269317-40269325 chr2:40269316-40269326 chr2:40269316-40269326 chr2:40269316-40269326 chr2:40269316-40269326 chr2:40269317-40269324
31	FOS	chr2:40269176-40269477	MCF10A-Er-Src	breast:	n/a	chr2:40269317-40269325 chr2:40269317-40269325 chr2:40269316-40269326 chr2:40269316-40269326 chr2:40269316-40269326 chr2:40269316-40269326 chr2:40269317-40269324
32	FOS	chr2:40266847-40266902	MCF10A-Er-Src	breast:	n/a	chr2:40266882-40266891 chr2:40266882-40266889 chr2:40266880-40266891 chr2:40266881-40266891 chr2:40266881-40266891
33	FOS	chr2:40266722-40267046	MCF10A-Er-Src	breast:	n/a	chr2:40266882-40266891 chr2:40266882-40266889 chr2:40266880-40266891 chr2:40266881-40266891 chr2:40266881-40266891 chr2:40266804-40266816
34	FOS	chr2:40266847-40266970	MCF10A-Er-Src	breast:	n/a	chr2:40266882-40266891 chr2:40266882-40266889 chr2:40266880-40266891 chr2:40266881-40266891 chr2:40266881-40266891
35	FOS	chr2:40260114-40260440	MCF10A-Er-Src	breast:	n/a	n/a
36	FOS	chr2:40259879-40260572	HUVEC	blood vessel:	n/a	n/a
37	FOS	chr2:40260101-40260505	MCF10A-Er-Src	breast:	n/a	n/a
38	FOS	chr2:40261422-40261614	MCF10A-Er-Src	breast:	n/a	chr2:40261493-40261504
39	FOS	chr2:40261437-40261543	MCF10A-Er-Src	breast:	n/a	chr2:40261493-40261504
40	FOS	chr2:40260103-40260434	MCF10A-Er-Src	breast:	n/a	n/a
41	FOS	chr2:40266811-40267020	MCF10A-Er-Src	breast:	n/a	chr2:40266882-40266891 chr2:40266882-40266889 chr2:40266880-40266891 chr2:40266881-40266891 chr2:40266881-40266891
42	FOSL2	chr2:40269221-40269429	HepG2	liver:	n/a	chr2:40269317-40269325 chr2:40269317-40269325 chr2:40269316-40269326 chr2:40269316-40269326 chr2:40269316-40269326 chr2:40269316-40269326 chr2:40269317-40269324
43	FOSL2	chr2:40260055-40260399	SK-N-SH	brain:	n/a	n/a
44	FOSL2	chr2:40259875-40260567	SK-N-SH	brain:	n/a	n/a
45	FOXP2	chr2:40276896-40277213	SK-N-MC	brain:	n/a	n/a
46	GATA2	chr2:40276744-40278009	SH-SY5Y	brain:	n/a	chr2:40277408-40277416
47	GATA2	chr2:40259870-40260489	HUVEC	blood vessel:	n/a	n/a
48	GATA2	chr2:40265768-40266187	SH-SY5Y	brain:	n/a	n/a
49	GATA2	chr2:40261334-40261716	HUVEC	blood vessel:	n/a	n/a
50	GATA3	chr2:40265781-40266278	MCF-7	breast:	n/a	chr2:40266056-40266064

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:40266366-40266416	SAEC	small airway:	n/a
2	chr2:40260498-40260548	HIPEpiC	eye:	n/a
3	chr2:40266366-40266416	LNCaP	prostate:	n/a
4	chr2:40266366-40266416	HCPEpiC	choroid plexus:	n/a
5	chr2:40260498-40260548	GM12892	blood:	n/a
6	chr2:40266366-40266416	AG04450	lung:	fetal
7	chr2:40260498-40260548	HEEpiC	esophagus:	n/a
8	chr2:40260498-40260548	K562	blood:	n/a
9	chr2:40260498-40260548	AoSMC	blood vessel:	n/a
10	chr2:40266366-40266416	H1-hESC	embryonic stem cell:	embryo
11	chr2:40266366-40266416	AoSMC	blood vessel:	n/a
12	chr2:40260498-40260548	GM12878	blood:	n/a
13	chr2:40266366-40266416	AG09309	skin:	n/a
14	chr2:40260498-40260548	HEK293	kidney:	embryo
15	chr2:40260498-40260548	NHDF-neo	bronchial:	n/a
16	chr2:40266366-40266416	HEK293	kidney:	embryo
17	chr2:40260498-40260548	MCF10A-Er-Src	breast:	n/a
18	chr2:40260498-40260548	HCF	heart:	n/a
19	chr2:40266366-40266416	BE2_C	brain:	n/a
20	chr2:40266366-40266416	HepG2	liver:	n/a
21	chr2:40260498-40260548	PANC-1	pancreas:	n/a
22	chr2:40266366-40266416	T-47D	breast:	n/a
23	chr2:40260498-40260548	H1-hESC	embryonic stem cell:	embryo
24	chr2:40266366-40266416	RPTEC	kidney:	n/a
25	chr2:40260498-40260548	NT2-D1	testis:	n/a
26	chr2:40266366-40266416	NH-A	brain:	n/a
27	chr2:40266366-40266416	SK-N-SH_RA	brain:	n/a
28	chr2:40266366-40266416	HL-60	blood:	n/a
29	chr2:40260498-40260548	NH-A	brain:	n/a
30	chr2:40260498-40260548	GM06990	blood:	n/a
31	chr2:40266366-40266416	NT2-D1	testis:	n/a
32	chr2:40266366-40266416	CMK	blood:	n/a
33	chr2:40260498-40260548	PFSK-1	brain:	n/a
34	chr2:40260498-40260548	BJ	skin:	n/a
35	chr2:40260498-40260548	AG10803	skin:	n/a
36	chr2:40266366-40266416	HNPCEpiC	eye:	n/a
37	chr2:40260498-40260548	GM12891	blood:	n/a
38	chr2:40266366-40266416	HCM	heart:	n/a
39	chr2:40266366-40266416	HRCEpiC	kidney:	n/a
40	chr2:40266366-40266416	GM06990	blood:	n/a
41	chr2:40260498-40260548	PrEC	prostate:	n/a
42	chr2:40266366-40266416	HCT-116	colon:	n/a
43	chr2:40266366-40266416	K562	blood:	n/a
44	chr2:40266366-40266416	HEEpiC	esophagus:	n/a
45	chr2:40266366-40266416	HUVEC	blood vessel:	n/a
46	chr2:40266366-40266416	PFSK-1	brain:	n/a
47	chr2:40260498-40260548	SAEC	small airway:	n/a
48	chr2:40266366-40266416	ovcar-3	ovarian:	n/a
49	chr2:40260498-40260548	ProgFib	skin:	n/a
50	chr2:40266366-40266416	Hela-S3	cervix:	n/a

No.	Distal block	Cell Line	Cell type
1	chr2:40254887..40256636-chr2:40272268..40275019,2	K562	blood:
2	chr2:40254887..40256636-chr2:40272268..40275019,2	K562	blood:
3	chr2:40248216..40251072-chr2:40272085..40274359,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TMEM178-2	chr2:40269490-40269613	ENSG00000227028.1
2	lnc-TMEM178-2	chr2:40270558-40270682	ENSG00000227028.1

Variant related genes	Relation type
SLC8A1-AS1	TF binding region
SLC8A1-AS1	CpG island

Extended variants
information (count: 1458 )
Associated
traits (count: 62 )

Variant overlapped rSNPs/rCNVs (count:1458 , 50 per page) page: 1 2 3 4 5 6 7 ... 30

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2024420	chr2:40256218-40256219	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs530929075	chr2:40256230-40256231	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs569414981	chr2:40256250-40256251	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs12473190	chr2:40256265-40256266	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs567130864	chr2:40256301-40256302	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs371686804	chr2:40256315-40256316	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs72791018	chr2:40256319-40256320	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs193297111	chr2:40256363-40256364	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs183464301	chr2:40256371-40256372	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs114369161	chr2:40256377-40256378	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs148375805	chr2:40256472-40256473	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs535976038	chr2:40256475-40256476	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs79394290	chr2:40256513-40256514	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs200490350	chr2:40256524-40256525	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs373314634	chr2:40256537-40256538	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs534245699	chr2:40256538-40256539	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs572972469	chr2:40256550-40256551	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs188190856	chr2:40256553-40256554	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs2024419	chr2:40256554-40256555	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs553587881	chr2:40256573-40256574	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs368056435	chr2:40256620-40256621	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs141597993	chr2:40256621-40256622	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs371765978	chr2:40256648-40256649	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs191536722	chr2:40256657-40256658	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs183904904	chr2:40256685-40256686	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs559889566	chr2:40256698-40256699	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs542755249	chr2:40256747-40256748	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs530114403	chr2:40256758-40256759	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs12616013	chr2:40256774-40256775	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs78050895	chr2:40256776-40256777	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs189987851	chr2:40256801-40256802	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs571084237	chr2:40256889-40256890	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs532322877	chr2:40256897-40256898	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs550812913	chr2:40256910-40256911	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs568765282	chr2:40256929-40256930	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs536293711	chr2:40256936-40256937	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs181696010	chr2:40256955-40256956	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs566605101	chr2:40256977-40256978	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs187162459	chr2:40257009-40257010	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs570238712	chr2:40257026-40257027	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs553624730	chr2:40257034-40257035	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs578191409	chr2:40257035-40257036	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs190209781	chr2:40257054-40257055	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs557582924	chr2:40257080-40257081	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs147452811	chr2:40257122-40257123	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs72791020	chr2:40257143-40257144	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs560927398	chr2:40257147-40257148	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs573025509	chr2:40257171-40257172	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs1990592	chr2:40257186-40257187	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs139901037	chr2:40257209-40257210	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:62)

Disease	PMID	Source
Breast cancer	17393978	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Bladder cancer	21909424	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Medulloblastoma	20607354	CNVD
Leukemia	18628472	CNVD
Autism	22495311	CNVD
Autism	19521722	CNVD
Autism	18522746	CNVD
Non-small cell lung cancer	18927303	CNVD
Breast cancer	21785460	CNVD
Lung cancer	18438408	CNVD
Prostate cancer	21965145	CNVD
Breast cancer	16397240	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21508638	CNVD
Neurodevelopmental disorder	22521361	CNVD
Neurocytoma	17123091	CNVD
small cell lung cancer	20016488	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
Breast cancer	21364760	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	22522925	CNVD
Williams Syndrome	20824207	CNVD
T-cell lymphomas	22341440	CNVD
Pancreatic cancer	17952125	CNVD
Schizophrenia	23813976	CNVD

Chromatin state (count:212 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:40255000-40256800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
2	chr2:40255000-40257000	Enhancers	HSMMtube	muscle
3	chr2:40255000-40257200	Enhancers	HMEC	breast
4	chr2:40255000-40257200	Enhancers	HSMM	muscle
5	chr2:40255000-40257200	Enhancers	Osteobl	bone
6	chr2:40255000-40257400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
7	chr2:40255000-40258000	Enhancers	NHDF-Ad	bronchial
8	chr2:40255000-40260400	Enhancers	Muscle Satellite Cultured Cells	--
9	chr2:40255200-40256400	Enhancers	Monocytes-CD14+_RO01746	blood
10	chr2:40255200-40257000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
11	chr2:40255200-40257000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
12	chr2:40255200-40257000	Enhancers	Fetal Thymus	thymus
13	chr2:40255200-40257400	Enhancers	Primary monocytes fromperipheralblood	blood
14	chr2:40255400-40256400	Enhancers	Dnd41	blood
15	chr2:40255800-40256400	Enhancers	GM12878-XiMat	blood
16	chr2:40256000-40256400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
17	chr2:40256000-40256600	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
18	chr2:40256000-40256600	Enhancers	Thymus	Thymus
19	chr2:40256000-40257000	Enhancers	Primary B cells from cord blood	blood
20	chr2:40256200-40257200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
21	chr2:40256200-40259400	Weak transcription	NHEK	skin
22	chr2:40256400-40257000	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
23	chr2:40256400-40257200	Flanking Active TSS	GM12878-XiMat	blood
24	chr2:40256600-40257000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
25	chr2:40256600-40259200	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
26	chr2:40256800-40259600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
27	chr2:40257000-40257400	Enhancers	Monocytes-CD14+_RO01746	blood
28	chr2:40257000-40258600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
29	chr2:40257000-40259200	Weak transcription	Fetal Thymus	thymus
30	chr2:40257000-40259600	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
31	chr2:40257000-40259600	Weak transcription	HSMMtube	muscle
32	chr2:40257000-40261000	Weak transcription	Primary B cells from cord blood	blood
33	chr2:40257200-40258600	Weak transcription	HSMM	muscle
34	chr2:40257200-40258600	Weak transcription	Osteobl	bone
35	chr2:40257200-40259200	Weak transcription	HMEC	breast
36	chr2:40257400-40258400	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
37	chr2:40257400-40259200	Weak transcription	Primary monocytes fromperipheralblood	blood
38	chr2:40258000-40258600	Weak transcription	NHDF-Ad	bronchial
39	chr2:40258400-40263000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
40	chr2:40258600-40258800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
41	chr2:40258600-40261800	Enhancers	HSMM	muscle
42	chr2:40258600-40261800	Enhancers	Osteobl	bone
43	chr2:40258600-40262000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
44	chr2:40258600-40262200	Enhancers	NHDF-Ad	bronchial
45	chr2:40258800-40259000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
46	chr2:40259000-40259800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
47	chr2:40259200-40259600	Enhancers	Primary monocytes fromperipheralblood	blood
48	chr2:40259200-40260000	Enhancers	Fetal Thymus	thymus
49	chr2:40259200-40262400	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
50	chr2:40259200-40262400	Enhancers	HMEC	breast

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links